SAN FRANCISCO, July 1, 2013 — Fillmore Capital Partners (FCP), a San Francisco based private investment company, today announced the $100 million capitalization and spin-off of AlixaRx from Drumm Corp.
The business concept for AlixaRx, as well as the clinical and professional expertise to develop the cutting-edge pharmacy model, began more than four years ago at Drumm Corp., the holding company for FCP’s family of health care companies.
“AlixaRx was developed from the ground up by leveraging the comprehensive clinical and industry expertise within the FCP family of health care companies,” said Mr. Ron Silva, President and CEO of FCP. “Our leadership teams anticipated and understood the growing needs of the health care community that AlixaRx would address, as well as the government’s Medicare and Medicaid programs. We went to work to develop an automated, integrated pharmacy system that can serve multiple health care settings and providers.”
Mr. Silva further stated, “The establishment of AlixaRx as an independent, well-capitalized company is the next step to maximize the company’s potential growth while continuing the development of its industry leading technology.”
AlixaRx operates full-service pharmacies that are staffed with clinical pharmacists and pharmacy technicians who use automated dispensing technology, electronic medication cabinets, and advanced clinical software to meet the 24-hour-a-day, seven-day-a-week needs of patients and providers. Utilizing its onsite automated dispensing technology, AlixaRx provides timely access to vital medications for patients while reducing costs to the payer and delivering cost savings to the total health care system.
In less than two years, AlixaRx has developed a pharmacy operation creating approximately 300 jobs in the communities it serves. Given the current pace of AlixaRx’s growth, the company will become the leader in pharmacy automation serving the post-acute health care sector.
“There are more than 17,000 skilled nursing facilities that can benefit from the AlixaRx advanced system,” said Mr. Silva. “AlixaRx’s growth strategy includes expanding into other health care settings outside of the post-acute sector. We are in discussions with multiple health care providers who see the value that AlixaRx can bring to their patients and residents.”
The company will maintain its headquarters in the Dallas Metroplex. For more information, visit AlixaRx’s website at www.alixarx.com.
About AlixaRx Pharmacy Services (www.alixarx.com)
AlixaRx provides advanced pharmacy services in post-acute health care facilities through a new model that leverages technology to deliver medication therapy management. AlixaRx offers a differentiated approach by utilizing a combination of clinical pharmacists and pharmacy technicians, automated dispensing technology, and electronic medication cabinets to meet the medication needs of patients in
each care setting. AlixaRx delivers improved safety, creates better access to medications, and produces time and cost savings in post-acute, skilled nursing, and other health care settings.
About Fillmore Capital Partners (www.fillmorecap.com)
Fillmore Capital Partners, LLC (FCP) is a private investment company that engages in the development, management, and distribution of investment vehicles for institutional and private investors. FCP invests in large health care, lodging, and operating company platforms, as well as opportunistic investments in other asset classes.
7160 Dallas Parkway, Suite 400
Plano, TX 75024